Literature DB >> 21745448

Preferential expression of integrin αvβ8 promotes generation of regulatory T cells by mouse CD103+ dendritic cells.

Helena Païdassi1, Mridu Acharya, Ailiang Zhang, Subhankar Mukhopadhyay, Manjae Kwon, Camille Chow, Lynda M Stuart, John Savill, Adam Lacy-Hulbert.   

Abstract

BACKGROUND & AIMS: Immune responses in the intestine are controlled by regulatory T cells (Tregs), which prevent inflammation in response to commensal bacteria. A specific population of intestinal dendritic cells (DCs), marked by expression of CD103, generate Tregs more efficiently than other DC populations through mechanisms that involve retinoic acid and transforming growth factor (TGF)-β. However, it is not clear how CD103(+) DCs are specialized for this function. We investigated the ability of CD103(+) DCs to promote Treg generation through activation of TGF-β and the role of integrins with the αv subunit in this process.
METHODS: Naïve T cells were cultured with purified DCs from mesenteric lymph nodes (MLNs) or intestines of wild-type and αv conditional knockout mice to assess generation of Tregs. Antigens were administered orally to mice, and antigen-specific generation of Tregs was measured in intestinal tissues. Expression of the integrin αv subunit was measured in purified subpopulations of DCs by quantitative polymerase chain reaction and immunoblot analyses.
RESULTS: In vitro, CD103(+) DCs generated more Tregs in the presence of latent TGF-β than other MLN DCs. Efficient generation of Tregs required expression of the integrin αv subunit by DCs; mice that lacked αv in immune cells did not convert naïve T cells to intestinal Tregs in response to oral antigen. CD103(+) DCs derived from the MLNs selectively expressed high levels of integrin αvβ8 compared with other populations of DCs.
CONCLUSIONS: Expression of αvβ8 is required for CD103(+) DCs to become specialized and activate latent TGF-β and generate Tregs during the induction of tolerance to intestinal antigens in mice.
Copyright © 2011 AGA Institute. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21745448      PMCID: PMC3202651          DOI: 10.1053/j.gastro.2011.06.076

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  28 in total

1.  Ulcerative colitis and autoimmunity induced by loss of myeloid alphav integrins.

Authors:  Adam Lacy-Hulbert; Aileen M Smith; Hamid Tissire; Marc Barry; Denise Crowley; Roderick T Bronson; Jürgen T Roes; John S Savill; Richard O Hynes
Journal:  Proc Natl Acad Sci U S A       Date:  2007-09-25       Impact factor: 11.205

Review 2.  Unravelling the pathogenesis of inflammatory bowel disease.

Authors:  R J Xavier; D K Podolsky
Journal:  Nature       Date:  2007-07-26       Impact factor: 49.962

3.  Learning tolerance while fighting ignorance.

Authors:  Philippe J Sansonetti; Ruslan Medzhitov
Journal:  Cell       Date:  2009-08-07       Impact factor: 41.582

4.  Selective ablation of alphav integrins in the central nervous system leads to cerebral hemorrhage, seizures, axonal degeneration and premature death.

Authors:  Joseph H McCarty; Adam Lacy-Hulbert; Alain Charest; Roderick T Bronson; Denise Crowley; David Housman; John Savill; Jürgen Roes; Richard O Hynes
Journal:  Development       Date:  2004-12-02       Impact factor: 6.868

5.  Selective imprinting of gut-homing T cells by Peyer's patch dendritic cells.

Authors:  J Rodrigo Mora; Maria Rosa Bono; N Manjunath; Wolfgang Weninger; Lois L Cavanagh; Mario Rosemblatt; Ulrich H Von Andrian
Journal:  Nature       Date:  2003-07-03       Impact factor: 49.962

6.  T cell-produced transforming growth factor-beta1 controls T cell tolerance and regulates Th1- and Th17-cell differentiation.

Authors:  Ming O Li; Yisong Y Wan; Richard A Flavell
Journal:  Immunity       Date:  2007-05-03       Impact factor: 31.745

7.  Intestinal epithelial cells promote colitis-protective regulatory T-cell differentiation through dendritic cell conditioning.

Authors:  I D Iliev; E Mileti; G Matteoli; M Chieppa; M Rescigno
Journal:  Mucosal Immunol       Date:  2009-04-22       Impact factor: 7.313

8.  Retinoic acid increases Foxp3+ regulatory T cells and inhibits development of Th17 cells by enhancing TGF-beta-driven Smad3 signaling and inhibiting IL-6 and IL-23 receptor expression.

Authors:  Sheng Xiao; Hulin Jin; Thomas Korn; Sue M Liu; Mohamed Oukka; Bing Lim; Vijay K Kuchroo
Journal:  J Immunol       Date:  2008-08-15       Impact factor: 5.422

9.  Generation of gut-homing IgA-secreting B cells by intestinal dendritic cells.

Authors:  J Rodrigo Mora; Makoto Iwata; Bertus Eksteen; Si-Young Song; Tobias Junt; Balimkiz Senman; Kevin L Otipoby; Aya Yokota; Hajime Takeuchi; Paola Ricciardi-Castagnoli; Klaus Rajewsky; David H Adams; Ulrich H von Andrian
Journal:  Science       Date:  2006-11-17       Impact factor: 47.728

10.  Absence of integrin-mediated TGFbeta1 activation in vivo recapitulates the phenotype of TGFbeta1-null mice.

Authors:  Zhiwei Yang; Zhenyu Mu; Branka Dabovic; Vladimir Jurukovski; Dawen Yu; Joanne Sung; Xiaozhong Xiong; John S Munger
Journal:  J Cell Biol       Date:  2007-03-12       Impact factor: 10.539

View more
  59 in total

1.  Soluble factors secreted by glioblastoma cell lines facilitate recruitment, survival, and expansion of regulatory T cells: implications for immunotherapy.

Authors:  Courtney A Crane; Brian J Ahn; Seunggu J Han; Andrew T Parsa
Journal:  Neuro Oncol       Date:  2012-03-09       Impact factor: 12.300

Review 2.  Vitamin A and immune regulation: role of retinoic acid in gut-associated dendritic cell education, immune protection and tolerance.

Authors:  Barbara Cassani; Eduardo J Villablanca; Jaime De Calisto; Sen Wang; J Rodrigo Mora
Journal:  Mol Aspects Med       Date:  2011-11-22

3.  The intestinal micro-environment imprints stromal cells to promote efficient Treg induction in gut-draining lymph nodes.

Authors:  S Cording; B Wahl; D Kulkarni; H Chopra; J Pezoldt; M Buettner; A Dummer; U Hadis; M Heimesaat; S Bereswill; C Falk; U Bode; A Hamann; D Fleissner; J Huehn; O Pabst
Journal:  Mucosal Immunol       Date:  2013-08-14       Impact factor: 7.313

4.  Crawling of effector T cells on extracellular matrix: role of integrins in interstitial migration in inflamed tissues.

Authors:  Chang H Kim
Journal:  Cell Mol Immunol       Date:  2013-09-23       Impact factor: 11.530

5.  CD55 Is Essential for CD103+ Dendritic Cell Tolerogenic Responses that Protect against Autoimmunity.

Authors:  Michael G Strainic; Jinbo Liu; Fengqi An; Erin Bailey; Andrew Esposito; Jörg Hamann; Peter S Heeger; M Edward Medof
Journal:  Am J Pathol       Date:  2019-05-17       Impact factor: 4.307

6.  Oral CD103-CD11b+ classical dendritic cells present sublingual antigen and induce Foxp3+ regulatory T cells in draining lymph nodes.

Authors:  Y Tanaka; H Nagashima; K Bando; L Lu; A Ozaki; Y Morita; S Fukumoto; N Ishii; S Sugawara
Journal:  Mucosal Immunol       Date:  2016-05-11       Impact factor: 7.313

7.  Retinoic acid primes human dendritic cells to induce gut-homing, IL-10-producing regulatory T cells.

Authors:  G Bakdash; L T C Vogelpoel; T M M van Capel; M L Kapsenberg; E C de Jong
Journal:  Mucosal Immunol       Date:  2014-07-16       Impact factor: 7.313

8.  Mesenteric lymph node CD11b- CD103+ PD-L1High dendritic cells highly induce regulatory T cells.

Authors:  Aya Shiokawa; Ryutaro Kotaki; Tomohiro Takano; Haruyo Nakajima-Adachi; Satoshi Hachimura
Journal:  Immunology       Date:  2017-06-01       Impact factor: 7.397

9.  Adipose-Derived Stem Cells Ameliorate Experimental Murine Colitis via TSP-1-Dependent Activation of Latent TGF-β.

Authors:  Hiroshi Takeyama; Tsunekazu Mizushima; Mamoru Uemura; Naotsugu Haraguchi; Junichi Nishimura; Taishi Hata; Chu Matsuda; Ichiro Takemasa; Masakazu Ikenaga; Kohei Murata; Hirofumi Yamamoto; Yuichiro Doki; Masaki Mori
Journal:  Dig Dis Sci       Date:  2017-04-22       Impact factor: 3.199

Review 10.  TGF-β: guardian of T cell function.

Authors:  Soyoung A Oh; Ming O Li
Journal:  J Immunol       Date:  2013-10-15       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.